Literature DB >> 11555179

Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.

G El Korchi1, C Prats, M Arboix, B Pérez.   

Abstract

Two commercially available long-acting oxytetracycline (OTC) formulations were administered by the intramuscular (i.m.) route to six healthy pigs at the recommended dose of 30 mg/kg. After 2 h the mean maximum concentration (C(max)) reached values of 8.1 +/- 2.2 and 15.4 +/- 11.1 microg/mL, respectively. These concentrations remained higher than 0.5 microg/mL for more than 5 days after drug administration. The area under the concentration time curve (AUC09 days) of each formulation was 255 +/- 76.5 and 399.2 +/- 123 microg. h/mL, respectively, and the mean residence time (MRT) was around 3 days for both formulations. No significant differences were observed between the pharmacokinetic parameters of the two formulations, showing the bioequivalence of the two formulations studied according to the criteria established by the Food and Drug Administration (FDA) and the Committee for Veterinary Medicinal Products (CVMP).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555179     DOI: 10.1046/j.1365-2885.2001.00342.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  4 in total

1.  Bioequivalence study of two long-acting oxytetracycline formulations in sheep.

Authors:  N Ozdemir; M Yildirim
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

2.  Pharmacokinetics of Free Oxytetracycline and Oxytetracycline Loaded Cockle Shell Calcium Carbonate-Based Nanoparticle in BALB/c Mice.

Authors:  Sherifat Banke Idris; Arifah Abdul Kadir; Jesse F F Abdullah; Siti-Zubaidah Ramanoon; Muhammad Abdul Basit; Md Zuki Z A Abubakar
Journal:  Front Vet Sci       Date:  2020-06-16

3.  Antimicrobial susceptibility profiles of Mycoplasma hyorhinis strains isolated from five European countries between 2019 and 2021.

Authors:  Ulrich Klein; Dorottya Földi; Nikolett Belecz; Veronika Hrivnák; Zoltán Somogyi; Michele Gastaldelli; Marianna Merenda; Salvatore Catania; Arkadiusz Dors; Ute Siesenop; Philip Vyt; Zsuzsa Kreizinger; Wouter Depondt; Miklós Gyuranecz
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

4.  Antibacterial Residue Excretion via Urine as an Indicator for Therapeutical Treatment Choice and Farm Waste Treatment.

Authors:  María Jesús Serrano; Diego García-Gonzalo; Eunate Abilleira; Janire Elorduy; Olga Mitjana; María Victoria Falceto; Alicia Laborda; Cristina Bonastre; Luis Mata; Santiago Condón; Rafael Pagán
Journal:  Antibiotics (Basel)       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.